These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

172 related items for PubMed ID: 6323142

  • 1. Functional receptors for vasoactive intestinal peptide on human osteosarcoma cells.
    Hohmann EL, Tashjian AH.
    Endocrinology; 1984 Apr; 114(4):1321-7. PubMed ID: 6323142
    [Abstract] [Full Text] [Related]

  • 2. Characterization of vasoactive intestinal peptide receptors in human colonic epithelial cells.
    Broyart JP, Dupont C, Laburthe M, Rosselin G.
    J Clin Endocrinol Metab; 1981 Apr; 52(4):715-21. PubMed ID: 6259191
    [Abstract] [Full Text] [Related]

  • 3. Receptors for vasoactive intestinal peptide and pituitary adenylate cyclase-activating polypeptide in turkey cerebral cortex: characterization by [125I]-VIP binding and effects on cyclic AMP synthesis.
    Zawilska JB, Niewiadomski P, Nowak JZ.
    Gen Comp Endocrinol; 2004 Jun; 137(2):187-95. PubMed ID: 15158130
    [Abstract] [Full Text] [Related]

  • 4. Vasoactive intestinal peptide binding to specific receptors on rat parotid acinar cells induces amylase secretion accompanied by intracellular accumulation of cyclic adenosine 3'-5'-monophosphate.
    Inoue Y, Kaku K, Kaneko T, Yanaihara N, Kanno T.
    Endocrinology; 1985 Feb; 116(2):686-92. PubMed ID: 2578385
    [Abstract] [Full Text] [Related]

  • 5. Vasoactive intestinal peptide receptor regulation of cAMP accumulation and glycogen hydrolysis in the human Ewing's sarcoma cell line WE-68.
    Van Valen F, Jürgens H, Winkelmann W, Keck E.
    Cell Signal; 1989 Feb; 1(5):435-46. PubMed ID: 2561912
    [Abstract] [Full Text] [Related]

  • 6. Vasoactive intestinal peptide receptor regulation and reversible desensitization in human colonic carcinoma cells in culture.
    Boissard C, Marie JC, Hejblum G, Gespach C, Rosselin G.
    Cancer Res; 1986 Sep; 46(9):4406-13. PubMed ID: 3015387
    [Abstract] [Full Text] [Related]

  • 7. Molecular identification and structural requirement of vasoactive intestinal peptide (VIP) receptors in the human colon adenocarcinoma cell line, HT-29.
    Couvineau A, Rousset M, Laburthe M.
    Biochem J; 1985 Oct 01; 231(1):139-43. PubMed ID: 2998337
    [Abstract] [Full Text] [Related]

  • 8. A human melanoma-derived cell line (IGR39) with a very high number of vasoactive-intestinal-peptide (VIP) receptors. 2. Effect of VIP on cAMP production and on cell-surface VIP-binding sites.
    Martin JM, Luis J, Marvaldi J, Pichon J, Pic P.
    Eur J Biochem; 1989 Mar 15; 180(2):435-9. PubMed ID: 2538331
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Vasoactive intestinal peptide effects on GH3 pituitary tumor cells: high affinity binding, affinity labeling, and adenylate cyclase stimulation. Comparison with peptide histidine isoleucine and growth hormone-releasing factor.
    Wood CL, O'Dorisio MS, Vassalo LM, Malarkey WB, O'Dorisio TM.
    Regul Pept; 1985 Nov 07; 12(3):237-48. PubMed ID: 3001842
    [Abstract] [Full Text] [Related]

  • 15. IL-1 binds to high affinity receptors on human osteosarcoma cells and potentiates prostaglandin E2 stimulation of cAMP production.
    Rodan SB, Wesolowski G, Chin J, Limjuco GA, Schmidt JA, Rodan GA.
    J Immunol; 1990 Aug 15; 145(4):1231-7. PubMed ID: 2166111
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Characterization of vasoactive intestinal peptide receptors on rat alveolar macrophages.
    Sakakibara H, Shima K, Said SI.
    Am J Physiol; 1994 Sep 15; 267(3 Pt 1):L256-62. PubMed ID: 7943252
    [Abstract] [Full Text] [Related]

  • 18. Interaction of vasoactive intestinal peptide with a cell line (HeLa) derived from human carcinoma of the cervix: binding to specific sites and stimulation of adenylate cyclase.
    Prieto JC, Guerrero JM, de Miguel C, Goberna R.
    Mol Cell Biochem; 1981 Jul 15; 37(3):167-76. PubMed ID: 6268963
    [Abstract] [Full Text] [Related]

  • 19. Regulation by vasoactive intestinal peptide, histamine, somatostatin-14 and -28 of cyclic adenosine monophosphate levels in gastric glands isolated from the guinea pig fundus or antrum.
    Gespach C, Hui Bon Hoa D, Rosselin G.
    Endocrinology; 1983 May 15; 112(5):1597-606. PubMed ID: 6131813
    [Abstract] [Full Text] [Related]

  • 20. Forskolin-induced homologous desensitization via an adenosine 3',5'-monophosphate-dependent mechanism(s) in human osteoblast-like SaOS-2 cells.
    Fukayama S, Tashjian AH, Bringhurst FR.
    Endocrinology; 1992 Oct 15; 131(4):1770-6. PubMed ID: 1327719
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.